Real world outcomes in patients with recurrent, advanced, or metastatic endometrial cancer treated with lenvatinib plus pembrolizumab

Real world outcomes in patients with recurrent, advanced, or metastatic endometrial cancer treated with lenvatinib plus pembrolizumab

.

Saved in:
Bibliographic Details
Main Authors: A. Pawsey, P. Mahalingam, N. Senthivel, A. Ramessur, E. Turnbull, S. Usman, R. Browne, A. Patel, A. Stewart, L. Tookman, N. Counsell, R. Miller, S. Nicum, G. Eminowicz
Format: Article
Language:Russian
Published: ABV-press 2025-05-01
Series:Опухоли женской репродуктивной системы
Subjects:
рак эндометрия
ленватиниб
пембролизумаб
переносимость
токсичность
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1354
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items